Top-performing pharma stocks in India in 2023
Top-performing pharma stocks in India: The pharmaceutical sector makes a significant contribution to the economy of any country. Currently, the pharmaceutical industry makes up about 1.72% of the GDP of India. This post will discuss valuable insights into the pharma sector that will help you make better investment decisions.
The Indian pharmaceutical industry is currently ranked 3rd in pharmaceutical production after evolving over time into a thriving industry and growing at a CAGR of 9.43% over the past nine years. India has the largest number of pharmaceutical manufacturing facilities that are US Food and Drug Administration (USFDA) compliant and has over 500 API producers that makeup about 8% of the worldwide API market. This makes India the largest provider of generic drugs globally, making India a leading country for affordable vaccines and generic drugs.
Over 50% of the world’s demand for various vaccines is met by the Indian pharmaceutical industry, as is 40% of the US market for generic drugs and 25% of the UK market for all medicines. 10,500 production facilities and 3,000 pharmaceutical businesses make up the domestic pharmaceutical industry.
A new EY FICCI analysis projects that by the end of 2030, the Indian pharmaceutical business will be worth USD 130 billion. In the meantime, it is predicted that the size of the global market for pharmaceutical products would surpass US$1 trillion in 2023.
Top-performing pharma stocks in India in 2023
The below list encompasses the Top performing pharma stocks in India in the last year. This list of the best pharmaceuticals is based on stock growth in the last year.
| S. No | Company Name | Stock Growth | Market Cap (in Crores) |
|---|---|---|---|
| 1 | Medico Remedies Ltd. | 318.14% | ₹ 802.46 |
| 2 | Hindustan Bioscience Limited | 179.60% | ₹ 759.72 |
| 3 | Newland Lab | 174.56% | ₹ 3,520.71 |
| 4 | Syschem India Limited | 149.53% | ₹ 136.40 |
| 5 | Pharmaids Pharmaceuticals Limited | 131.87% | ₹ 67.72 |
| 6 | Cian Healthcare | 100.89% | ₹ 94.88 |
| 7 | Mercury Labs | 91.21% | ₹ 108.99 |
| 8 | Themis Medicare | 83.70% | ₹ 1401.67 |
| 9 | Shukra Pharma | 82.23% | ₹ 118.58 |
| 10 | Guj Themis | 75.26% | ₹ 1072.22 |
| 11 | TTK Healthcare | 69.08% | ₹ 1,779.86 |
| 12 | Vikram Thermo | 60.83% | ₹ 262.12 |
| 13 | Unichem Labs | 58.88% | ₹ 2,624.37 |
| 14 | Glemark Pharmacetical Ltd. | 49.94% | ₹ 16,801.70 |
| 15 | Roopa Industries Ltd. | 44.31% | ₹ 33.02 |
Best-performing pharma stocks in India: An Overview
Medico Remedies Ltd.
Medico Remedies Limited was incorporated in 1994. It is a small-cap company with a market capitalisation of ₹ 802.46 crore. When we analyse the 52-week performance of the stock, it touched the highest of ₹ 92 and the lowest of ₹ 16.52, with this stock showing the highest growth rate of 318.54% during the past year in the pharmaceutical sector. It is a pharmaceutical formulation manufacturing company with manufacturing and marketing capabilities for manufacturing a wide range of tablets, capsules, oral suspensions, syrups, ointments, creams, and injectables.
Hindustan Bioscience Limited
Established in 2000. Hindustan Biosciences Limited (HBSL) is an integrated firm with diversified operations in the pharmaceutical and biotechnology sectors. When we analyse the 52-week performance of the stock, it touched the highest of ₹ 92 and the lowest of ₹ 16.52. Their stock shows a growth rate of 179.60% during the past year. The company has a market capitalization of ₹ 759.72 crore.
Newland Lab
Established in 1984, Hyderabad, India-based Neuland Laboratories Limited is now a publicly traded company. Neuland is a top producer of active pharmaceutical ingredients (APIs) and a complete solution supplier for the chemistry requirements of the pharmaceutical industry. Neuland has been at the forefront of enabling and speeding drug development and cGMP manufacture of APIs for more than three decades. The business’s technical and scientific teams offer the pharmaceutical industry around the world complete solutions and services.
When we analyse the 52-week performance of the stock, it touched the highest of ₹ 3,042 and the lowest of ₹ 967, with this stock showing a growth rate of 174.56% during the past year.
Syschem India Limited
System (India) Limited (SIL) was incorporated in 1993. It is a small-cap company with a market capitalisation of ₹ 136.40 crore. The company is engaged in the manufacture of bulk drugs, intermediates, speciality chemicals, and contract manufacturing. When we analyse the 52-week performance of the stock, it touched the highest of ₹ 65.10 and the lowest of ₹ 16.50, with this stock showing a growth rate of 149.53% during the past year.
Pharmaids Pharmaceuticals Limited
Pharmaids Pharmaceuticals Limited was incorporated in 1989. The company engaged in the business of supplying a quality-grade range of speciality chemicals, skin care, hospital care, and generic products in the areas of orthopaedics, neurology, gastroenterology, etc.
It is a small-cap company with a market capitalisation of ₹ 67.72 crore. When we analyse the 52-week performance of the stock, it touched the highest of ₹ 31.45 and the lowest of ₹ 10.17, with this stock showing a growth rate of 131.87% during the past year.
Cian Healthcare
Cian Healthcare is a pharmaceutical company founded in 2003. The company portfolio comprises of gynaecology, haematinic, cardio-diabetic, orthopaedic, paediatric, derma-cosmetic, antibiotic, CNS, vitamins & nutrient products.
It is a small-cap company with a market capitalisation of ₹ 94.88 crore. When we analyse the 52-week performance of the stock, it touched the highest of ₹ 40.42 and the lowest of ₹ 12, with this stock showing a growth rate of 100.89% during the past year.
Mercury Labs
Mercury Labs was incorporated in 1982. It is a small-cap pharmaceutical company with a market capitalisation of ₹ 108.99 crore. For more than six decades, the company has been at the forefront of formulating, developing, marketing, and distributing safe, innovative, and cost-effective pharmaceuticals that help to improve the quality of life of patients.
When we analyse the 52-week performance of the stock, it touched the highest of ₹ 1,000 and the lowest of ₹ 390, with this stock showing a growth rate of 91.21% during the past year.
Themis Medicare Limited
Themis Medicare, incorporated in 1969, is a small-cap pharmaceutical company with a market capitalisation of ₹ 1401.67 crores. The company is well known for developing novel formulations and manufacturing APIs. Its main focus is innovative drug delivery systems (NDDS), including relatively painless injections like ETOJET and life-saving medications like EMAL.
When we analyse the 52-week performance of the stock, it touched the highest of ₹ 1,700 and the lowest of ₹ 686.45, with this stock showing a growth rate of 83.70% during the past year.
Shukra Pharmaceuticals Ltd.
Shukra Pharmaceuticals Ltd. was incorporated in 1993. It is a small-cap pharmaceutical company having a market capitalisation of ₹ 118.58 crores. When we analyse the 52-week performance of the stock, it touched the highest of ₹ 132 and the lowest of ₹ 11.67, with this stock showing a growth rate of 82.23% during the past year.
Guj Themis
The company was incorporated in 1981. Guj Themis is engaged in the manufacturing of pharmaceuticals and medicinal chemical products. The company operates through the manufacturing of bulk drugs segment.
It is a small-cap company with a market capitalisation of ₹ 1072.22 crore. When we analyse the 52-week performance of the stock, it touched the highest of ₹ 921.05 and the lowest of ₹ 376.10, with this stock showing a growth rate of 75.26% during the past year.
TTK Healthcare
TTK Healthcare came into being in 1928. It is a pharmaceutical company with a modern and diversified conglomerate and a wide range of products in the FMCG, pharmaceuticals, healthcare, and food industries.
It is a small-cap company with a market capitalisation of ₹ 1,779.86 crore. When we analyse the 52-week performance of the stock, it touched the highest of ₹ 1,474 and the lowest of ₹ 667, with this stock showing a growth rate of 69.08% during the past year.
Vikram Thermo
Vikram Thermo was incorporated in 1994. It is a pharmaceutical company. Pharmaceutical formulations rely heavily on pharmaceutical polymers. Thus, the critical axiom of Vikram Thermo remains to contribute to the most cost-effective and long-term preservation of human lives.
It is a small-cap company with a market capitalisation of ₹ 262.12 crore. When we analyse the 52-week performance of the stock, it touched the highest of ₹ 84 and the lowest of ₹ 34, with this stock showing a growth rate of 60.83% during the past year.
Unichem Labs
Unichem Laboratories was founded in 1944. It is one of India’s oldest and largest pharmaceutical companies. Its product segment includes formulations and bulk drugs.
It is a small-cap company with a market capitalization of ₹ 2,624.37 crore. When we analyse the 52-week performance of the stock, it touched the highest of ₹ 466.95 and the lowest of ₹ 230.30, with this stock showing a growth rate of 58.88% during the past year.
Also Read: Larsen & Toubro Stock Forecast: L&T Share Price Target
Glemark Pharmacetical Ltd.
The Glemark Pharmacetical Ltd. was founded in 1977. It is a generic drug and active pharmaceutical ingredient manufacturer. It is a mid-cap company with a market capitalization of ₹ 16,801.70 crore. When we analyse the 52-week performance of the stock, it touched the highest of ₹ 629.85 and the lowest of ₹ 348.50, with this stock showing a growth rate of 49.94% during the past year.
Roopa Industries Ltd.
Roopa Industries Ltd. was established in 2000. It is a growing active pharmaceutical ingredient (API) and pharmaceutical intermediates manufacturing company in India that has been steadily diversifying its product portfolio.
It is a small-cap company with a market capitalization of ₹ 33.02 crore. When we analyse the 52-week performance of the stock, it touched the highest of ₹ 92.75 and the lowest of ₹ 24.50, with this stock showing a growth rate of 44.31% during the past year.
